HighTower Advisors LLC Acquires New Holdings in Grail, Inc. (NASDAQ:GRAL)

HighTower Advisors LLC purchased a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 10,964 shares of the company's stock, valued at approximately $196,000.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Crcm LP purchased a new position in Grail in the fourth quarter valued at about $65,061,000. Bank of New York Mellon Corp acquired a new position in shares of Grail in the fourth quarter worth $6,262,000. TCW Group Inc. acquired a new position in Grail in the 4th quarter valued at about $5,095,000. abrdn plc purchased a new position in shares of Grail during the fourth quarter valued at approximately $3,768,000. Finally, Douglas Lane & Associates LLC acquired a new stake in Grail during the fourth quarter worth approximately $3,034,000.

Insiders Place Their Bets

In other Grail news, CEO Robert P. Ragusa sold 7,625 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the transaction, the chief executive officer now owns 828,662 shares in the company, valued at $25,862,541.02. The trade was a 0.91 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Aaron Freidin sold 1,816 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the transaction, the chief financial officer now owns 335,170 shares in the company, valued at approximately $10,457,304. This trade represents a 0.54 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 11,550 shares of company stock worth $360,436 over the last ninety days.

Remove Ads

Grail Stock Down 10.8 %

NASDAQ:GRAL traded down $2.59 during mid-day trading on Tuesday, reaching $21.39. The company's stock had a trading volume of 1,873,732 shares, compared to its average volume of 1,223,988. The company's fifty day simple moving average is $33.99 and its two-hundred day simple moving average is $22.97. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last released its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to analysts' expectations of $35.33 million. On average, research analysts forecast that Grail, Inc. will post -15.15 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Morgan Stanley boosted their price target on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a report on Tuesday, March 18th.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.